Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular
Johnson & Johnson acquires biotech Intra-Cellular for $14.6 billion, enhancing its portfolio in innovative therapies and expanding its market reach.
Read More
Author: max
These Stocks Are Moving the Most Today: Nvidia, Tesla, Moderna, Intra-Cellular Therapies, JPMorgan Chase, Lululemon, and More
Discover today’s top stock movers, including Nvidia, Tesla, Moderna, Intra-Cellular Therapies, JPMorgan Chase, and Lululemon. Stay informed!
Read MoreFormer First Republic Executive Joins $4 Billion Pennington Partners
Former First Republic executive joins Pennington Partners, enhancing leadership in the $4 billion firm with expertise in finance and strategic growth.
Read More
Invest in 3M Stock Before This Crucial Event, Analyst Advises
“Discover why analysts recommend investing in 3M stock ahead of a pivotal event that could impact its market performance. Act now!”
Read More
Unlocking PayPal’s Potential in 2025: The Fintech Stock’s Hidden Advantage
Discover how PayPal’s unique strengths position it for growth in 2025, revealing hidden advantages in the evolving fintech landscape.
Read More